Search research articles
Contact Us
Filters
Showing results (161-170 of 278) with videos related to
Page
of 28
Sort By:
American Journal of Clinical Pathology
|
May 19, 2005
Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia
C Cameron Yin, Armand B Glassman, Pei Lin, et al.
Cancer Genetics and Cytogenetics
|
February 2, 2010
Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms with or without JAK2 or MPL mutations
Laura Millecker, Patrick A Lennon, Srdan Verstovsek, et al.
World Journal of Gastroenterology
|
March 23, 2022
Recent advances in the diagnostic evaluation of pancreatic cystic lesions
Devarshi R Ardeshna, Troy Cao, Brandon Rodgers, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 6, 2011
Patterns of molecular response to and relapse after combination of sorafenib, idarubicin, and cytarabine in patients with FLT3 mutant acute myeloid leukemia
Aref Al-Kali, Jorge Cortes, Stefan Faderl, et al.
Cancer
|
December 19, 2007
The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas
Claudiu V Cotta, Vasiliki Leventaki, Vassilis Atsaves, et al.
American Journal of Clinical Pathology
|
September 11, 2002
Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections
George Z Rassidakis, Dan Jones, Athanasios Thomaides, et al.
The American Journal of Cardiology
|
March 24, 2007
Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke
Gerald F Fletcher, Vincent Bufalino, Fernando Costa, et al.
Blood
|
April 12, 2008
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy
Elias Jabbour, Hagop Kantarjian, Dan Jones, et al.
Cancer
|
August 31, 2010
Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapy
Farshid Dayyani, Hagop Kantarjian, Susan O'Brien, et al.
American Journal of Clinical Pathology
|
October 6, 2005
inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases
Mihai Merzianu, L Jeffrey Medeiros, Jorge Cortes, et al.
Page
of 28
Search research articles
Search
Showing results (161-170 of 278) with videos related to
Sort By:
Page
of 28
American Journal of Clinical Pathology
|
May 19, 2005
Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia
C Cameron Yin, Armand B Glassman, Pei Lin, et al.
Cancer Genetics and Cytogenetics
|
February 2, 2010
Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms with or without JAK2 or MPL mutations
Laura Millecker, Patrick A Lennon, Srdan Verstovsek, et al.
World Journal of Gastroenterology
|
March 23, 2022
Recent advances in the diagnostic evaluation of pancreatic cystic lesions
Devarshi R Ardeshna, Troy Cao, Brandon Rodgers, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 6, 2011
Patterns of molecular response to and relapse after combination of sorafenib, idarubicin, and cytarabine in patients with FLT3 mutant acute myeloid leukemia
Aref Al-Kali, Jorge Cortes, Stefan Faderl, et al.
Cancer
|
December 19, 2007
The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas
Claudiu V Cotta, Vasiliki Leventaki, Vassilis Atsaves, et al.
American Journal of Clinical Pathology
|
September 11, 2002
Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections
George Z Rassidakis, Dan Jones, Athanasios Thomaides, et al.
The American Journal of Cardiology
|
March 24, 2007
Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke
Gerald F Fletcher, Vincent Bufalino, Fernando Costa, et al.
Blood
|
April 12, 2008
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy
Elias Jabbour, Hagop Kantarjian, Dan Jones, et al.
Cancer
|
August 31, 2010
Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapy
Farshid Dayyani, Hagop Kantarjian, Susan O'Brien, et al.
American Journal of Clinical Pathology
|
October 6, 2005
inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases
Mihai Merzianu, L Jeffrey Medeiros, Jorge Cortes, et al.
Page
of 28